Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Intervalo de año de publicación
1.
Acta Trop ; 193: 23-30, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30771283

RESUMEN

BACKGROUND: Chagas disease is an important health problem in Latin America. Relatives of T. cruzi seropositive donors could also test positive in serological assays. Therefore, the study of Chagas diseases in family clusters has become important to accurately evaluate the problem that this infectious disease represents. OBJECTIVE: to investigate family cluster from blood donors, their serological, clinical and epidemiological status. METHODS: 53 family clusters consisting of index case and a variable number of relatives were studied. All the participants had ELISA and Western blot assays, as well as, clinical tests including an electrocardiogram and chest x ray. RESULTS: We found that 24.52% of the family clusters had at least one T. cruzi seropositive family member, in addition to the blood donor. Importantly, 20.75% of the index cases and 5.0% of the relatives presented pathological manifestations associated to Chagas disease. Several epidemiological conditions are associated to being T. cruzi seropositive. CONCLUSION: blood donor's family clusters have several seropositive to T. cruzi members. Mother-child pairs were also seropositive, suggesting vertical transmition. Pathological symptom associated to Chagas Diseases were present in index cases and family member. These results highlight the importance of studying family clusters to clarify the true magnitude of Chagas disease in Mexico.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Enfermedad de Chagas/epidemiología , Familia , Trypanosoma cruzi/inmunología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Donantes de Sangre/estadística & datos numéricos , Enfermedad de Chagas/sangre , Enfermedad de Chagas/diagnóstico , Niño , Preescolar , Análisis por Conglomerados , Femenino , Humanos , Masculino , México/epidemiología , Persona de Mediana Edad , Adulto Joven
2.
Cir Cir ; 76(4): 305-9, 2008.
Artículo en Español | MEDLINE | ID: mdl-18778540

RESUMEN

BACKGROUND: Frequency of adrenal insufficiency in patients with tuberculosis varies from 0 to 58%; however, all published series excluded severely ill patients. Our objective was to investigate adrenal insufficiency with the low-dose cosyntropin test in patients with severe active tuberculosis. METHOD: From two large university affiliated hospitals, 18 patients with tuberculosis and criteria of sepsis or severe sepsis according to SCCM/ACCP criteria, defined by the present authors as severe active tuberculosis, participated in the study. A low-dose ACTH test with 10 mg of ACTH was performed. After ACTH test, all patients received a stress dose of hydrocortisone (240 mg/day) during their entire hospitalization along with four antituberculous drugs. Abnormal response was considered when elevation of serum cortisol was <7 microg/dl with respect to basal level, 60 min after ACTH administration. RESULTS: Adrenal insufficiency was found in seven patients (39%); no clinical or laboratory data were associated with the presence of abnormal adrenal response. Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment. The increment in serum cortisol value post-ACTH test was lower in patients with hypoalbuminemia. CONCLUSIONS: Adrenal insufficiency is frequent in severe active tuberculosis. The efficacy and security of supplemental steroid treatment in severe active tuberculosis should be established by a randomized clinical trial.


Asunto(s)
Insuficiencia Suprarrenal/diagnóstico , Cosintropina , Hidrocortisona/sangre , Tuberculosis Pulmonar/complicaciones , Insuficiencia Suprarrenal/tratamiento farmacológico , Insuficiencia Suprarrenal/etiología , Adulto , Antituberculosos/uso terapéutico , Cosintropina/administración & dosificación , Quimioterapia Combinada , Etambutol/administración & dosificación , Femenino , Infecciones por VIH/complicaciones , Humanos , Hidrocortisona/metabolismo , Hidrocortisona/uso terapéutico , Isoniazida/uso terapéutico , Masculino , Persona de Mediana Edad , Pirazinamida/administración & dosificación , Rifampin/uso terapéutico , Sepsis/tratamiento farmacológico , Sepsis/etiología , Sepsis/fisiopatología , Tuberculosis Miliar/complicaciones , Tuberculosis Miliar/tratamiento farmacológico , Tuberculosis Miliar/fisiopatología , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/fisiopatología
3.
Cir. & cir ; 76(4): 305-309, jul.-ago. 2008. tab, graf
Artículo en Español | LILACS | ID: lil-568082

RESUMEN

BACKGROUND: Frequency of adrenal insufficiency in patients with tuberculosis varies from 0 to 58%; however, all published series excluded severely ill patients. Our objective was to investigate adrenal insufficiency with the low-dose cosyntropin test in patients with severe active tuberculosis. METHOD: From two large university affiliated hospitals, 18 patients with tuberculosis and criteria of sepsis or severe sepsis according to SCCM/ACCP criteria, defined by the present authors as severe active tuberculosis, participated in the study. A low-dose ACTH test with 10 mg of ACTH was performed. After ACTH test, all patients received a stress dose of hydrocortisone (240 mg/day) during their entire hospitalization along with four antituberculous drugs. Abnormal response was considered when elevation of serum cortisol was <7 microg/dl with respect to basal level, 60 min after ACTH administration. RESULTS: Adrenal insufficiency was found in seven patients (39%); no clinical or laboratory data were associated with the presence of abnormal adrenal response. Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment. The increment in serum cortisol value post-ACTH test was lower in patients with hypoalbuminemia. CONCLUSIONS: Adrenal insufficiency is frequent in severe active tuberculosis. The efficacy and security of supplemental steroid treatment in severe active tuberculosis should be established by a randomized clinical trial.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Cosintropina , Hidrocortisona/sangre , Insuficiencia Suprarrenal/diagnóstico , Tuberculosis Pulmonar/complicaciones , Antituberculosos/uso terapéutico , Cosintropina/administración & dosificación , Quimioterapia Combinada , Etambutol/administración & dosificación , Hidrocortisona , Hidrocortisona/uso terapéutico , Infecciones por VIH/complicaciones , Insuficiencia Suprarrenal/tratamiento farmacológico , Insuficiencia Suprarrenal/etiología , Isoniazida/uso terapéutico , Pirazinamida/administración & dosificación , Rifampin/uso terapéutico , Sepsis/tratamiento farmacológico , Sepsis/etiología , Sepsis/fisiopatología , Tuberculosis Miliar/complicaciones , Tuberculosis Miliar/tratamiento farmacológico , Tuberculosis Miliar/fisiopatología , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...